首页> 美国卫生研究院文献>Journal of Ginseng Research >Ginseng gintonin alleviates neurological symptoms in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis through lysophosphatidic acid 1 receptor
【2h】

Ginseng gintonin alleviates neurological symptoms in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis through lysophosphatidic acid 1 receptor

机译:人参磷素通过溶血磷脂酸1受体减轻了G93A-SOD1转基因硬化症的G93A-SOD1转基因小鼠模型中的神经症状

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We recently showed that gintonin, an active ginseng ingredient, exhibits antibrain neurodegenerative disease effects including multiple target mechanisms such as antioxidative stress and antiinflammation via the lysophosphatidic acid (LPA) receptors. Amyotrophic lateral sclerosis (ALS) is a spinal disease characterized by neurodegenerative changes in motor neurons with subsequent skeletal muscle paralysis and death. However, pathophysiological mechanisms of ALS are still elusive, and therapeutic drugs have not yet been developed. We investigate the putative alleviating effects of gintonin in ALS.
机译:我们最近表明,活性人参成分,表现出抗纤维神经退行性疾病作用,包括多种靶向机制,例如通过赖磷脂酸(LPA)受体等抗氧化应激和抗炎。肌营养的外侧硬化症(ALS)是一种脊柱疾病,其特征在于运动神经元的神经变化,随后骨骼肌麻痹和死亡。然而,ALS的病理生理机制仍然是难以捉摸的,并且尚未开发治疗药物。我们探讨了Gintonin在ALS中的推定缓解作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号